Ardelyx (ARDX) Equity Average (2014 - 2026)
Ardelyx (ARDX) reported Equity Average of $157.8 million for Q1 2026, down 1.06% on a YoY basis from $159.5 million in Q1 2025, and down 1.76% quarter-over-quarter from $160.6 million in Q4 2025.
Ardelyx (ARDX) Equity Average (2014 - 2026) Analysis & Trends
Ardelyx has reported Equity Average for 13 years, with the latest figure at $157.8 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 1.06% year-over-year to $157.8 million; the trailing twelve-month figure through Mar 2026 stood at $157.8 million (down 1.06% YoY), and the FY2025 full-year result was $170.1 million, changed 0.04% from the prior year.
- Equity Average for Q1 2026 stood at $157.8 million, down from $160.6 million in the prior quarter.
- The five-year high for Equity Average was $179.0 million in Q4 2023, with the low at $58.6 million in Q2 2022.
- Historically, Equity Average has averaged $131.8 million across 5 years, with a median of $148.9 million in 2024.
- Annual changes were most pronounced in 2022 — Equity Average slumped 52.8% — and 2023, when it surged 162.15%.
- Ardelyx's Equity Average stood at $82.6 million in 2022, then surged by 116.71% to $179.0 million in 2023, then retreated by 7.37% to $165.8 million in 2024, then declined by 3.12% to $160.6 million in 2025, then slipped by 1.76% to $157.8 million in 2026.
- The last three Equity Average figures came in at $157.8 million (Q1 2026), $160.6 million (Q4 2025), and $146.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 157.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.79 Mn |
| Dec 31, 2025 | 160.61 Mn |
| Sep 30, 2025 | 146.91 Mn |
| Jun 30, 2025 | 142.60 Mn |
| Mar 31, 2025 | 159.48 Mn |
| Dec 31, 2024 | 165.79 Mn |
| Sep 30, 2024 | 152.64 Mn |
| Jun 30, 2024 | 148.94 Mn |
| Mar 31, 2024 | 158.85 Mn |
| Dec 31, 2023 | 178.99 Mn |
| Sep 30, 2023 | 157.16 Mn |
| Jun 30, 2023 | 124.29 Mn |
| Mar 31, 2023 | 111.88 Mn |
| Dec 31, 2022 | 82.60 Mn |
| Sep 30, 2022 | 59.95 Mn |
| Jun 30, 2022 | 58.62 Mn |
| Mar 31, 2022 | 73.40 Mn |
| Dec 31, 2021 | 82.02 Mn |
| Sep 30, 2021 | 99.50 Mn |
| Jun 30, 2021 | 124.19 Mn |